Opiant Pharmaceuticals Inc (NASDAQ:OPNT)
| 20.12 Delayed Data As of Feb 02 |  +0.09 / +0.45%Today’s Change | 7.34 Today|||52-Week Range 32.27 | -0.79% Year-to-Date |
Latest OPNT News | Press Releases
No recent news for Opiant Pharmaceuticals Inc.
Today’s Trading
| Previous close | 20.03 |
| Today’s open | 20.05 |
| Day’s range | 20.00 - 20.11 |
| Volume | 5,513 |
| Average volume (3 months) | 81,114 |
| Market cap | $106.7M |
Data as of 3:59pm ET, 02/02/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -1,688.24% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +61.30% |
| P/E ratio | NM |
| Price/Sales | 4.17 |
| Price/Book | 2.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DAREDare Bioscience Inc | +0.02 | +2.02% |
| WWHCW World Corp | 0.00 | 0.00% |
| CAPRCapricor Therapeutic... | -0.06 | -1.42% |
| ---- |
Data as of 3:59pm ET, 02/02/2023
Financials
| Next reporting date | March 23, 2023 |
| EPS forecast (this quarter) | -$2.04 |
| Annual revenue (last year) | $47.8M |
| Annual profit (last year) | $3.0M |
| Net profit margin | 6.30% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Santa Monica, California |
Forecasts
